Professional medical (prescription) cannabis products were being rescheduled in the united kingdom in 2018 — this allowed professional Medical practitioners to prescribe cannabis-dependent medicines within a confined list of scenarios. Accessibility by using the NHS continues to be tightly limited: cannabis-primarily based products tend to be onl